---
title: Advancing Phenotypic Drug Discovery Through Data-Driven Single-Cell Profiling and AI in 2025
description: Discover how VisionSort can be used to advance drug discovery with morphological profiling and AI.
---

[Skip to content](https://info.thinkcyte.com/vs-for-drug-discovery-wp#main-content)

[![THINKCYTE-LOGO-DK-1000W](https://info.thinkcyte.com/hs-fs/hubfs/BRAND-ASSETS/THINKCYTE-LOGO-DK-1000W.png?width=225&height=41&name=THINKCYTE-LOGO-DK-1000W.png)](https://thinkcyte.com/)

Open main navigation

Close main navigation

- [Contact us](https://info.thinkcyte.com/contact-thinkcyte)

[Contact us](https://info.thinkcyte.com/contact-thinkcyte?hsLang=en)

Advancing Phenotypic Drug Discovery Through Data-Driven Single-Cell Profiling and AI in 2025

![WP26_Image](https://info.thinkcyte.com/hs-fs/hubfs/WP26_Image.jpg?width=465&name=WP26_Image.jpg "WP26_Image")

**Introduction**:

Drug discovery faces many challenges, most notably the low rate of progression from drug candidate to market  
release and the looming patent expiration of many best-selling drugs. This has increased the pressure on  
pharmaceutical companies to identify novel drug targets and lead molecules. VisionSort, a breakthrough platform leveraging Ghost Cytometry technology, provides a transformative solution. Ghost Cytometry leverages high-resolution morphological profiling and AI to provide a unique and holistic measure of cellular phenotype that can be leveraged for drug screening, enabling researchers to screen for new, complex disease-associated phenotypes  
that are not possible to find using conventional methods. In addition, the approach can be used to identify new drug targets as well as novel, rare, and disease-associated cell populations. 

Summary:

In this White Paper we discuss:

-The challenges facing drug discovery, particularly the increasing complexity of drug development.  
• The current landscape of life science approaches used in drug discovery and their limitations.  
• An overview of Ghost Cytometry technology and its key benefits over current approaches.  
• Case studies showing real-world applications of VisionSort to advance drug discovery.

Register to find out more.

Copyright © 2026, ThinkCyte Inc.